Association Between Skin Autofluorescence and White Blood Cell Counts in Older Adults

Overview

Journal In Vivo

Specialty Oncology

Date 2023 Oct 31

PMID 37905660

Authors

Yasuhisa Izushi

Keisuke Yoshii

Yuichi Tasaka

Kaori Matsumoto

Yoshihisa Kitamura

Kenichi Shimada

Affiliations

Soon will be listed here.

Abstract

Background/aim: Advanced glycation end products (AGEs) accumulate in the body with increasing age. However, their excessive accumulation may lead to various inflammatory and chronic diseases. While it is common for older adults to experience various comorbidities, there is a scarcity of published literature documenting the specific impact of ageing and comorbidities on AGEs in this population. The present study aimed to retrospectively evaluate the correlation among AGEs in the skin, calendar age, and comorbidities in older adults.

Patients And Methods: Accumulated AGEs in the skin were assessed by non-invasive measurement of skin autofluorescence (SAF) inside the forearm. This retrospective study included individuals who underwent SAF measurements at Shujitsu University Community Pharmacy with or without a prescription from October 2019 to October 2021. Subsequently, the associations between SAF, calendar age, comorbidities, and blood test parameters were investigated.

Results: SAF showed a positive correlation with calendar age for all enrolled participants; the correlation weakened for participants aged ≥50 years and plateaued for those aged ≥60 years. Furthermore, we observed a significant increase in SAF among all participants with comorbidities compared to those without comorbidities. By contrast, among participants aged ≥50 years, SAF did not show a significant association with comorbidities. However, SAF was significantly positively correlated with white blood cell (WBC) counts in these aged populations.

Conclusion: The non-invasive assessment of SAF holds promise in evaluating changes in the physical condition associated with WBC counts among older adults.

References

Xin C, Wang Y, Liu M, Zhang B, Yang S . Correlation analysis between advanced glycation end products detected noninvasively and skin aging factors. J Cosmet Dermatol. 2020; 20(1):243-248. DOI: 10.1111/jocd.13452. View

Demirer B, Samur G . Possible effects of dietary advanced glycation end products on maternal and fetal health: a review. Nutr Rev. 2022; 81(7):844-856. DOI: 10.1093/nutrit/nuac090. View

Chaudhuri J, Bains Y, Guha S, Kahn A, Hall D, Bose N . The Role of Advanced Glycation End Products in Aging and Metabolic Diseases: Bridging Association and Causality. Cell Metab. 2018; 28(3):337-352. PMC: 6355252. DOI: 10.1016/j.cmet.2018.08.014. View

Gorska-Ciebiada M, Saryusz-Wolska M, Borkowska A, Ciebiada M, Loba J . C-Reactive Protein, Advanced Glycation End Products, and Their Receptor in Type 2 Diabetic, Elderly Patients with Mild Cognitive Impairment. Front Aging Neurosci. 2015; 7:209. PMC: 4625092. DOI: 10.3389/fnagi.2015.00209. View

de Vos L, Mulder D, Smit A, Dullaart R, Kleefstra N, Lijfering W . Skin autofluorescence is associated with 5-year mortality and cardiovascular events in patients with peripheral artery disease. Arterioscler Thromb Vasc Biol. 2014; 34(4):933-8. DOI: 10.1161/ATVBAHA.113.302731. View

Corstjens H, Dicanio D, Muizzuddin N, Neven A, Sparacio R, Declercq L . Glycation associated skin autofluorescence and skin elasticity are related to chronological age and body mass index of healthy subjects. Exp Gerontol. 2008; 43(7):663-667. DOI: 10.1016/j.exger.2008.01.012. View

Yamanaka M, Matsumura T, Ohno R, Fujiwara Y, Shinagawa M, Sugawa H . Non-invasive measurement of skin autofluorescence to evaluate diabetic complications. J Clin Biochem Nutr. 2016; 58(2):135-40. PMC: 4788401. DOI: 10.3164/jcbn.15-132. View

Luevano-Contreras C, Chapman-Novakofski K . Dietary advanced glycation end products and aging. Nutrients. 2012; 2(12):1247-65. PMC: 3257625. DOI: 10.3390/nu2121247. View

Babtan A, Ilea A, Bosca B, Crisan M, Petrescu N, Collino M . Advanced glycation end products as biomarkers in systemic diseases: premises and perspectives of salivary advanced glycation end products. Biomark Med. 2019; 13(6):479-495. DOI: 10.2217/bmm-2018-0448. View

10.

Koetsier M, Lutgers H, de Jonge C, Links T, Smit A, Graaff R . Reference values of skin autofluorescence. Diabetes Technol Ther. 2010; 12(5):399-403. DOI: 10.1089/dia.2009.0113. View

11.

Yamagishi S . Potential clinical utility of advanced glycation end product cross-link breakers in age- and diabetes-associated disorders. Rejuvenation Res. 2012; 15(6):564-72. DOI: 10.1089/rej.2012.1335. View

12.

Horner D, Taal M . Skin autofluorescence: an emerging biomarker in persons with kidney disease. Curr Opin Nephrol Hypertens. 2019; 28(6):507-512. DOI: 10.1097/MNH.0000000000000549. View

13.

Ashraf J, Ahmad S, Choi I, Ahmad N, Farhan M, Tatyana G . Recent advances in detection of AGEs: Immunochemical, bioanalytical and biochemical approaches. IUBMB Life. 2015; 67(12):897-913. DOI: 10.1002/iub.1450. View

14.

Isami F, West B, Nakajima S, Yamagishi S . Association of advanced glycation end products, evaluated by skin autofluorescence, with lifestyle habits in a general Japanese population. J Int Med Res. 2018; 46(3):1043-1051. PMC: 5972252. DOI: 10.1177/0300060517736914. View

15.

Meerwaldt R, Graaff R, Oomen P, Links T, Jager J, Alderson N . Simple non-invasive assessment of advanced glycation endproduct accumulation. Diabetologia. 2004; 47(7):1324-1330. DOI: 10.1007/s00125-004-1451-2. View

16.

Cavero-Redondo I, Soriano-Cano A, Alvarez-Bueno C, Cunha P, Martinez-Hortelano J, Garrido-Miguel M . Skin Autofluorescence-Indicated Advanced Glycation End Products as Predictors of Cardiovascular and All-Cause Mortality in High-Risk Subjects: A Systematic Review and Meta-analysis. J Am Heart Assoc. 2018; 7(18):e009833. PMC: 6222966. DOI: 10.1161/JAHA.118.009833. View

17.

Zaigham S, Persson M, Jujic A, Frantz S, Borne Y, Malinovschi A . Measures of lung function and their relationship with advanced glycation end-products. ERJ Open Res. 2020; 6(2). PMC: 7261968. DOI: 10.1183/23120541.00356-2019. View

18.

Ichihara K, Yomamoto Y, Hotta T, Hosogaya S, Miyachi H, Itoh Y . Collaborative derivation of reference intervals for major clinical laboratory tests in Japan. Ann Clin Biochem. 2015; 53(Pt 3):347-56. DOI: 10.1177/0004563215608875. View

19.

Kanda Y . Investigation of the freely available easy-to-use software 'EZR' for medical statistics. Bone Marrow Transplant. 2012; 48(3):452-8. PMC: 3590441. DOI: 10.1038/bmt.2012.244. View

20.

Gerrits E, Lutgers H, Kleefstra N, Graaff R, Groenier K, Smit A . Skin autofluorescence: a tool to identify type 2 diabetic patients at risk for developing microvascular complications. Diabetes Care. 2007; 31(3):517-21. DOI: 10.2337/dc07-1755. View